Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
HMG-CoA Reductase
More Information »3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase) catalyzes the rate limiting step in cholesterol biosynthesis - conversion of 3-hydroxy-3-methyl-glutaryl-CoA to mevalonic acid. HMG-CoA reductase is a transmembrane enzyme, bound to endoplasmic reticulum.
HMG-CoA Reductase Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 3776 | Atorvastatin hemicalcium salt |
| HMG-CoA reductase inhibitor | |
| 3309 | Fluvastatin sodium |
| HMG-CoA reductase inhibitor | |
| 1530 | Lovastatin |
| HMG-CoA reductase inhibitor | |
| 1526 | Mevastatin |
| HMG-CoA reductase inhibitor | |
| 2318 | Pravastatin sodium salt |
| HMG-CoA reductase inhibitor | |
| 1965 | Simvastatin |
| HMG-CoA reductase inhibitor | |
Other |
|
Cat.No. |
Product Name / Activity |
| 2969 | SR 12813 |
| Enhances HMG-CoA reductase degradation. Also PXR agonist | |


